Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase
申请人:Metabasis Therapeutics, Inc.
公开号:US06489476B1
公开(公告)日:2002-12-03
FBPase inhibitors of the formula I and X
are useful in the treatment of diabetes and other conditions associated with elevated blood glucose or excess glycogen storage.
公式I和X的FBPase抑制剂在治疗糖尿病和其他与血糖升高或多余糖原贮存有关的疾病中很有用。
Novel bisamidate phosphonate prodrugs
申请人:METABASIS THERAPEUTICS, INC.
公开号:US20020173490A1
公开(公告)日:2002-11-21
Novel bisamidate phosphonate prodrugs of FBPase inhibitors of the Formula IA:
1
and their use in the treatment of diabetes and other conditions associated with elevated blood glucose.
Electrochemical Properties of Ru Polypyridyl Phosphonates
作者:Hashini N. K. Herath、Austin L. MacRae、Angel Ugrinov、Glenn R. Morello、Alexander R. Parent
DOI:10.1002/ejic.202200747
日期:——
Ru complexes containing polypyridyl phosphonate ligands were synthesized and characterized spectroscopically and electrochemically. Each compound was found to exhibit proton-coupled electron transfer (PCET).